ParticipantsJeremy Middleton, MD, Los Angeles, CA (Presenter) Nothing to Disclose
Maitraya K. Patel, MD, Los Angeles, CA (Abstract Co-Author) Nothing to Disclose
Rinat Masamed, MD, Los Angeles, CA (Abstract Co-Author) Nothing to Disclose
Haatal B. Dave, MD, MS, Marina Del Rey, CA (Abstract Co-Author) Nothing to Disclose
Steven S. Raman, MD, Santa Monica, CA (Abstract Co-Author) Consultant, Johnson & Johnson; Consultant, Bayer AG; Consultant, Merck & Co, Inc; Consultant, Amgen Inc; Consultant, Profound Medical Inc
Simin Bahrami, MD, Manhattan Beach, CA (Abstract Co-Author) Nothing to Disclose
jmiddleton@mednet.ucla.edu
TEACHING POINTSFibroids are a significant cause of morbidity in the United States and worldwide. The International Federation of Gynecology and Obstetrics (FIGO) sub-classification of abnormal uterine bleeding provides a concise system for communication of fibroid anatomy, with clinical and management implications. Objectives include: a. Understand the key imaging features of fibroids and FIGO sub-classification of fibroid anatomy b. Review imaging features of classic as well as atypical/degenerative fibroids, common variant presentations, and findings suspicious for malignancy c. Appreciate the utility of ultrasound and MRI modalities in initial work-up, problem-solving, pre-treatment planning, and post-treatment follow-up including expected imaging appearance and review of complications
TABLE OF CONTENTS/OUTLINE1. Introduction 2. Review of fibroids 3. FIGO classification of fibroids 4. Atypical/degenerative fibroids 5. Common diagnostic pitfalls 6. Imaging features that raise suspicion for malignancy 7. Management options and impact of pre-treatment imaging 8. Post-treatment findings and common complications 9. Summary